Sep 6, 2022
Generic versions of Galvus are due to be launched by generic manufacturers in the coming weeks, so what is the future for Vildagliptin? There is a ‘honeymoon’ period after generics are launched during which the original brand manufacturer can profitably...
Aug 30, 2022
In light of the increases to the rebates that branded and brand-generic manufacturers have to return to the NHS under the VPAS voluntary and statutory schemes, with forecast rebates of 25% in 2023 we thought it worth having a look at the amount of effort each type of...
Aug 19, 2022
The companies making and selling branded products need to understand how well their efforts are working to convince GPs to prescribe their brands. The graphic below shows a number of branded generics, however changes in the way they are reimbursed (VPAS) means that...
Aug 18, 2022
The companies making and selling branded products need to understand how well their efforts are working to convince GPs to prescribe their brands. Some companies are impressed by the orders sales people get from wholesalers, pharmacies and dispensing doctors. However...
Jul 11, 2022
To get a feel for this we looked at one pack of Lundbeck’s Cipralex and a pack of the generic Escitalopram as we wanted to see how the shortage and price rise of the generic in 2019 affected the brand. Although the drug tariff came down from £14.91 at the start...
Jul 6, 2022
Generic shortages are often triggered when the average market price falls to a level at which manufacturers can no longer make a profit. At this point they cancel manufacturing orders, the stock in the market is used up by dispensing to patients, free stock declines...
